MAOB and psychotic disorder: Varnas et al. (2020) reported from a PET study of the human brain that both antagonists bind to monoamine oxidase-B (MAO-B), which reveals a new understanding of psychosis-like adverse effects and could generate new models for the pathophysiology of psychosis [93].